United Kingdom · Life Sciences Lvl3
Immunokey Ltd
Immunokey Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Sep 2026.
Announcements
Innovate UK funding awarded
£98,478 · Innovation Loans; “VivoKey - Development of a novel delivery method for CARKey in Ovarian Cancer”; North West
Innovate UK funding awarded
£419,996 · Investment Accelerator grant; “OVAKey: Unlocking Ovarian Cancer with CARKey technology”; North West
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.